This week, surgeons discover a Phillips-head screw buried under a woman’s retina, a novel implant bypasses the eyes to restore vision and researchers share updates on a stem cell and gene therapies for retinitis pigmentosa. Source: AAO
This study evaluated adjuvant corneal crosslinking (CXL) for treatment of filamentous fungal keratitis. Source: AAO
Novartis has launched a safety review of their new anti-VEGF agent brolucizumab (Beovu) following reports of possible unintended side effects after the drug was approved last October. Source: AAO
This paper focuses on corneal and glaucoma outcomes among patients with Peters anomaly. Source: AAO
The authors describe an evolutionary algorithm that designs biological machines—an approach that could one day possibly be used to safely deliver drugs or repair damaged tissue inside the human body. Source: AAO
This study presents outcomes of patients treated with ranibizumab for branch and central retinal vein occlusion (BRVO and CRVO). Source: AAO
This week, Chinese scientists unveil color-changing contacts that respond to ocular fluctuations, Alcon’s allergy eye drops are now available over the counter and a blue laser attack nearly blinds a highway patrol pilot. Source: AAO
In this extension trial, investigators compared the effect of continued or discontinued use of omega-3 fatty acid supplements among participants of the DREAM study. Source: AAO
This literature review compares the efficacy of 3 of the most commonly employed endophthalmitis prophylaxis antibiotics: cefuroxime, vancomycin and moxifloxacin. Source: AAO
The authors described a case of a 6-year-old girl who developed bilateral optic neuritis following inactivated influenza vaccination. Source: AAO